IL1B and neoplasm: While some studies reported that 5-FU decreased immunosuppressive myeloid and Treg cell populations consistent with enhancing anti-tumour immunity, 5-FU also was shown to activate the inflammasome in dying myeloid cells leading to IL-1β secretion that increased angiogenesis and stimulated tumour growth.